Thanks Bella, it’s going to happen. It’s just a massive lesson in patience & keeping your eye on researching the environment around your chosen biotech stocks. There is a lot of research out there on CKD/DKD & the effects of COVID-19. Go to DXB board as well, no cross promotion, as we are in collaboration on Ph2b DKD trial, PromarkerD no news yet, but some articles & results you may find interesting.
None of us had any inkling when we invested in either stock, the impact COVID-19 would have globally on Public Health & beyond; in the diagnosis, treatment & recovering from the initial infection from this virus - leading to chronic & complex disease states for a relatively high proportion of cases. We have always known viruses can attack the pancreas & induce Type 1 diabetes, but this is new research in a novel disease (Long COVID-19) & the scientific community are still learning on SARS-COV2:
https://www.google.com.au/amp/s/amp.theaustralian.com.au/world/the-times/virus-can-trigger-diabetes-growing-evidence-suggests/news-story/d2f2d934fd09c099c9db827ec2f2d9f9Access restricted on the above article unless you subscribe to The Australian.
https://www.google.com.au/amp/s/amp.news.com.au/lifestyle/health/health-problems/growing-evidence-suggests-covid19-could-trigger-diabetes/news-story/818379bd81b61fe1d2173a3e17156a62https://www.google.com.au/amp/s/www.cbsnews.com/amp/news/covid-19-new-diabetes-cases-linked/I haven’t yet had the time to look into research, but it’s all over the media now, including for children with suspected viral induced DM Type 1.
We knew it was coming. Something to look into.
@no vice, I hope you have gotten used to the roller coaster ride here now. On FA, I see every reason to hold, wish I had opportunity to trade & pick up profits along the way, buy more on dips, but my job is not conducive with that, so happy to sit tight as well.
GLTAH
(20min delay)